Drug therapy possibilities for various forms of chronic rhinitis accompanied by dry nose syndrome

Abstract

Introduction. Dry nose syndrome is a polyetiological condition that is common among patients of all age groups from infancy to profoundly old age. The low effectiveness of treatment is associated with the progression of atrophic mucous membrane degeneration, which also affects the cartilaginous and bony parts of the nasal cavity. Significant impairment of the protective, respiratory and olfactory function leads to decreased quality of life of patients, delayed adaptation, and arrested psychosomatic and physical development of children. Herbal medications refer to the agents that have minimal toxicity and side effects and effectively facilitate the restoration of functional integrity of the mucous membrane.Aim. To discuss the results of studies on the effectiveness of natural medicines in the treatment of patients with dry nose syndrome.Materials and methods. We conducted a literature search and studied publications (articles and relevant abstracts) containing information on various diseases that are accompanied by dry nose syndrome, as well as therapeutic options for this syndrome in Russian and foreign databases. The material was selected according to the following keywords: dry nose syndrome, atrophic rhinitis, mint essential oil, pine essential oil, eucalyptus essential oil. The study was conducted using the search engines Scopus, PubMed, CyberLeninka, Elibrary.ru, Google Scholar.Results and discussion. The study results suggested the potential and benefits of the topical use of a combination medicine containing essential oils of eucalyptus, mint, and pine as a treatment and prophylactic medication in patients with dry nose syndrome.Conclusion. Dyshesol, a herbal medicine that is an oil solution, meets the requirements for complex pathogenetic therapy in patients with dry nose syndrome of various etiologies, and can be recommended as a preventive and therapeutic medication for all age groups, and children from the age of two.